Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06874595 · ClinicalTrials.gov registry record · NA

Psychobiological Responses Following Exercise and Brain Stimulation

A NA study of Psychological, sponsored by Virginia Commonwealth University.

Recruiting
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT06874595 is a NA study of Psychological that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 29 participants, below the 646-participant average among 9 other Psychological trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06874595, a NA study of Psychological, is actively recruiting participants, sponsored by Virginia Commonwealth University.

RECRUITING
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

Anxiety disorders are the most common mental health diagnosis in the US; 19.1% of U.S. adults (23.4% for females and 14.3% for males). In addition, the Global Burden of Disease study (2010) found that anxiety disorders were the sixth leading cause of disability (years of life lived with disability). These debilitating disorders are characterized by excessive worry and fear about everyday situations, and physical symptoms including restlessness, being easily fatigued, difficulty concentrating, irritability, muscle tension, or sleep disturbance. Furthermore, anxiety is linked to other mental disorders including depression and substance abuse; is associated with cardiovascular disease risk factors and a higher rate of cardiovascular disease; and is related to premature mortality. These data have led to the investigation of a breadth of plausible treatments for anxiety, including medications and psychotherapy. However, likely due to the breadth of complex mechanisms involved in the pathophysiology of anxiety disorders and the unfavorable side effects of various medications, a considerable number of individuals do not have a satisfactory response to these treatments. This has led investigators to examine plausible novel interventions to alleviate anxiety and its symptoms.

Conditions Studied

Interventions

  • OTHER Cycling exercise at 65% of HRR for 20 minutes followed by HD-tDCS (exercise + HD-tDCS)
  • OTHER Cycling exercise at 65% of HRR exercise followed by sham HD-tDCS (exercise + sham tDCS)
  • OTHER No exercise followed by HD-tDCS (no exercise + HD-tDCS).
  • OTHER State Anxiety Inventory
  • OTHER Visual Analog Scale for Anxiety

Study Locations (1)

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2025-03-19
Est. Completion 2027-02
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT06874595

The ClinicalTrials.gov registry entry for NCT06874595 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 646-participant average among 9 other Psychological trials with a reported enrollment target (96% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Psychological appearing as the primary indexed condition, and to 5 interventions - of which Cycling exercise at 65% of HRR for 20 minutes followed by HD-tDCS (exercise + HD-tDCS) is the first listed.

NCT06874595 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT06874595 about?

NCT06874595 is a clinical study titled "Psychobiological Responses Following Exercise and Brain Stimulation". Anxiety disorders are the most common mental health diagnosis in the US; 19.1% of U.S. adults (23.4% for females and 14.3% for males). In addition, the Global Burden of Disease study (2010) found that anxiety disorders were the sixth leading cause of disability (years of life lived with disability)....

What is the current status of trial NCT06874595?

This trial is currently recruiting. It is a NA study. The enrollment target is 29 participants. The study started on 2025-03-19. Estimated completion is 2027-02.

What conditions does trial NCT06874595 study?

This clinical trial studies the following conditions: Psychological.

What interventions are being tested in trial NCT06874595?

The interventions under investigation include: Cycling exercise at 65% of HRR for 20 minutes followed by HD-tDCS (exercise + HD-tDCS) (OTHER), Cycling exercise at 65% of HRR exercise followed by sham HD-tDCS (exercise + sham tDCS) (OTHER), No exercise followed by HD-tDCS (no exercise + HD-tDCS). (OTHER), State Anxiety Inventory (OTHER), Visual Analog Scale for Anxiety (OTHER).

Who is sponsoring clinical trial NCT06874595?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06874595 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychological

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.